May 31, 2018
Diabetes is becoming more common. But access to appropriate care for people living with diabetes? Not so much. So explains a new white paper from the Institute for Patient Access.
May 29, 2018
Many people think they know Tourette syndrome. It’s the person who blurts out foul words at inopportune times, like what you see on sitcoms or in movies. In reality, this particular vocal tic is rare. But the stereotype of people living with Tourette syndrome is unfortunately common.
May 25, 2018
The 340B Drug Pricing Program was designed to encourage health care facilities to provide care for uninsured or underinsured patients.…
May 24, 2018
Certain elements are critical to the health care that patients with cystic fibrosis need. The Cystic Fibrosis Engagement Network has identified those elements in its new Health Care Bill of Rights for Individuals with Cystic Fibrosis, released this week.
May 22, 2018
Only one-fourth of the 6 million women with endometriosis could be treated with a new GnRH antagonist and still meet the Institute for Clinical and Economic Review’s budget threshold, according to a report released by the organization. The new drug has shown promise in clinical trials to lessen the pain associated with endometriosis, which can cause painful menstrual periods and even infertility.
May 19, 2018
On April 17, 2018, the Institute for Patient Access convened the third annual National Policy and Advocacy Summit…
May 18, 2018
A massive stroke marked a serious change in the weather for Mark McEwen, whose familiar face brought viewers the weather forecast on the 1990s’ “CBS This Morning.” McEwen keynoted the May 15 Cardiovascular Health Policy Summit in Washington, DC, describing how he struggled to regain speech, mobility and fine motor skills.
May 17, 2018
Heart patients in Europe have something to celebrate. This week, the European Commission approved a groundbreaking new drug, evolocumab, to prevent heart attack and stroke for patients who have already survived a cardiac event.
May 15, 2018
New research suggests that President Donald Trump, U.S. senators and the country’s physicians may agree on at least one thing: the federal 340B drug pricing program deserves more scrutiny. Designed to encourage care for indigent and underinsured patients, the program has ballooned into a revenue stream for growing hospital systems.
May 15, 2018
The 340B Drug Pricing Program was designed to encourage health care facilities to provide care for uninsured or underinsured patients.…
